Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
13.33
-0.03 (-0.19%)
Apr 17, 2025, 4:00 PM EDT - Market closed
TCMD Market Cap
TCMD has a market cap or net worth of $315.47 million as of April 17, 2025. Its market cap has decreased by -13.14% in one year.
Market Cap
315.47M
Enterprise Value
266.21M
1-Year Change
-13.14%
Ranking
Category
Stock Price
$13.33
Market Cap Chart
Since July 28, 2016, TCMD's market cap has increased from $184.50M to $315.47M, an increase of 70.98%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 314.40M | -23.52% |
| Dec 31, 2024 | 411.10M | 22.35% |
| Dec 29, 2023 | 336.00M | 45.20% |
| Dec 30, 2022 | 231.40M | -38.65% |
| Dec 31, 2021 | 377.20M | -56.79% |
| Dec 31, 2020 | 872.90M | -32.05% |
| Dec 31, 2019 | 1.28B | 52.67% |
| Dec 31, 2018 | 841.40M | 64.02% |
| Dec 29, 2017 | 513.00M | 85.94% |
| Dec 30, 2016 | 275.90M | 49.54% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |